Skip to content
Abierto
Menu

Presolicitation

Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients.

75N98026Q00392

National Institutes of Health, National Institutes of Health Olao. General Medical and Surgical Hospitals.

View on SAM.govMarkdown

Awarded

Loyola University of Chicago

$350,000.00 obligated so far on USAspending

Description

As published on SAM.gov.

Attachment: Notice of Intent to Sole Source

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Loyola University of Chicago
UEI
RFRPFMNR8LA5
CAGE
9M268
Vendor location
Maywood, IL
Contract
75N98026P01477, purchase order
Obligated
$350,000.00, potential $1,400,000
Actions
1 between September 8, 2026 and September 8, 2026
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Modification to the A11 Herv-E TCR and T Cell Product Toimprove the Therapeutic Efficacy for CCRCC Patients
Match
solicitation number 75N98026Q00392 equals the FPDS solicitation identifier; same awarding office 75N980 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 19, 2026

    Presolicitation

    Due June 3, 2026 at 9:00 AM EDT. SAM.gov, notice 649cdc32e3ab4fd791566e2135050a49

Points of contact

Also open from this buyer